e-Drug3D

317

URACIL MUSTARD

DISCONTINUED


INN
URACIL MUSTARD

cas 66-75-1
CLASS

ANTINEOPLASTIC
ALKYLATING AGENT
TREATMENT OF LYMPHOMA, CHRONIC LYMPHATIC LEUKEMIA, AND THROMBOCYTHEMIA

ROUTE (list)

ORAL

ATC code

L01AD08

PK parameters

Target

TARGET DNA

DrugCentral

Unknown

Download SDF file 5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione

Formula:
C8H11Cl2N3O2

Calculated chemical properties:

MW 252.10
NB_atoms 15
XLogP 0.35
PSA 62.607
NB_HD 2
NB_HA 5
fsp3 0.50
Lipinski(0=no;1=yes) 1

FDA
NDA 012892 (pdf not found) INN (URACIL MUSTARD) URACIL MUSTARD (SHIRE) APPROVAL= AP YEAR= 1962 NEWMOLECULARENTITY DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL